Distinguishing on current imaging between disease progression and pseudo progression in patients with glioblastoma is one of the most difficult clinical problems, according to Manmeet Ahluwalia, MD and Pallavi Tiwari, PhD.
Pallavi Tiwari, PhD
Advertisement
Pallavi Tiawari, PhD is an associate professor, Department of Radiology, Biomedical Engineering, Medical Physics, University of Wisconsin-Madison; co-director, Imaging and Radiation Science, Carbone Cancer Center.
Articles by Pallavi Tiwari, PhD
Advertisement
Latest Updated Articles
Gender-Specific AI Model Advances Understanding of Glioblastoma Progression and Treatment ResponsePublished: September 21st 2022 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
